PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23846683-1	2013	Covalently linked carboxyl-terminal segments of the beta-amyloid peptide (Abeta) were tested for their qualification as minimal conformational epitopes of the naturally occurring human autoantibodies against beta-amyloid (nAbs-Abeta).	nabs	222-226	amyloid beta precursor protein	Homo sapiens	52-72	
23846683-1	2013	Covalently linked carboxyl-terminal segments of the beta-amyloid peptide (Abeta) were tested for their qualification as minimal conformational epitopes of the naturally occurring human autoantibodies against beta-amyloid (nAbs-Abeta).	nabs	222-226	amyloid beta precursor protein	Homo sapiens	227-232	
23846683-2	2013	nAbs-Abeta specifically recognize the toxic oligomers of Abeta and not the monomeric or the fibrillar forms of Abeta.	nabs	0-4	amyloid beta precursor protein	Homo sapiens	5-10	
23846683-2	2013	nAbs-Abeta specifically recognize the toxic oligomers of Abeta and not the monomeric or the fibrillar forms of Abeta.	nabs	0-4	amyloid beta precursor protein	Homo sapiens	57-62	
23846683-2	2013	nAbs-Abeta specifically recognize the toxic oligomers of Abeta and not the monomeric or the fibrillar forms of Abeta.	nabs	0-4	amyloid beta precursor protein	Homo sapiens	57-62	
23846683-7	2013	Synthetic peptide epitopes with high affinities for nAbs-Abeta are needed to identify the physiological roles of nAbs-Abeta and are promising epitopes for vaccination experiments.	nabs	52-56	amyloid beta precursor protein	Homo sapiens	57-62	
23846683-7	2013	Synthetic peptide epitopes with high affinities for nAbs-Abeta are needed to identify the physiological roles of nAbs-Abeta and are promising epitopes for vaccination experiments.	nabs	52-56	amyloid beta precursor protein	Homo sapiens	118-123	
23846683-7	2013	Synthetic peptide epitopes with high affinities for nAbs-Abeta are needed to identify the physiological roles of nAbs-Abeta and are promising epitopes for vaccination experiments.	nabs	113-117	amyloid beta precursor protein	Homo sapiens	57-62	
23846683-7	2013	Synthetic peptide epitopes with high affinities for nAbs-Abeta are needed to identify the physiological roles of nAbs-Abeta and are promising epitopes for vaccination experiments.	nabs	113-117	amyloid beta precursor protein	Homo sapiens	118-123	
22903668-7	2012	This chapter summarizes our current knowledge on NAbs against Abeta.	nabs	49-53	amyloid beta precursor protein	Homo sapiens	62-67	
23209707-3	2012	Previously, we and others have shown that natural human IgGs (NAbs) target diverse Abeta conformers and have therapeutic potential.	nabs	62-66	amyloid beta precursor protein	Homo sapiens	83-88	
23209707-5	2012	Importantly, NAbs also recognized Abeta extracted from the water-soluble phase of human AD brain, including species that migrated on denaturing PAGE as SDS-stable dimers.	nabs	13-17	amyloid beta precursor protein	Homo sapiens	34-39	
23209707-7	2012	The antibody"s lack of reactivity against a linear sequence epitope was confirmed by our ability to isolate anti-Abeta NAbs from intravenous immunoglobulin using affinity matrices, immunoglobulin light chain fibrils and Cibacron blue, which had no sequence similarity with the peptide.	nabs	119-123	amyloid beta precursor protein	Homo sapiens	113-118	
23209707-8	2012	These findings suggest that further investigations on the molecular basis and the therapeutic/diagnostic potential of anti-Abeta NAbs are warranted.	nabs	129-133	amyloid beta precursor protein	Homo sapiens	123-128	
20329802-6	2010	Beyond the occurrence of nAbs-Abeta, evidence for several other mechanisms associated with IVIG in AD has been reported in preclinical experiments and clinical studies.	nabs	25-29	amyloid beta precursor protein	Homo sapiens	30-35	
33523832-3	2021	NAbs-Abeta levels in plasma and cerebrospinal fluid (CSF) were tested according to their epitopes.	nabs	0-4	amyloid beta precursor protein	Homo sapiens	5-10	
33523832-4	2021	Levels of NAbs targeting the amino terminus of Abeta increased, and those targeting the mid-domain of Abeta decreased in both CSF and plasma in AD patients.	nabs	10-14	amyloid beta precursor protein	Homo sapiens	47-52	
33523832-5	2021	Higher plasma levels of NAbs targeting the amino terminus of Abeta and lower plasma levels of NAbs targeting the mid-domain of Abeta were associated with higher brain amyloidosis at baseline and faster cognitive decline during follow-up.	nabs	24-28	amyloid beta precursor protein	Homo sapiens	61-66	
33523832-5	2021	Higher plasma levels of NAbs targeting the amino terminus of Abeta and lower plasma levels of NAbs targeting the mid-domain of Abeta were associated with higher brain amyloidosis at baseline and faster cognitive decline during follow-up.	nabs	94-98	amyloid beta precursor protein	Homo sapiens	127-132	
27802290-3	2016	Therefore, we explored nAbs against alpha-synuclein (alphaS), tau and beta-amyloid (Abeta) in PDD compared to cognitively normal PD patients.	nabs	23-27	amyloid beta precursor protein	Homo sapiens	84-89	
27802290-8	2016	Though, due to a high interassay coefficient of variability and the exclusion of many samples below the limit of detection, conclusions for nAbs-Abeta are only conditionally possible.	nabs	140-144	amyloid beta precursor protein	Homo sapiens	145-150